Cardinal Health (NYSE:CAH) 株価情報

Cardinal Health

Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Earnings

Equities

News

Futures

Previews

Economics

Federal Reserve

Pre-Market Outlook

Markets

Movers

Trading Ideas

$BTC

CSCO

GOOGL

HNHPF

LITE

NVDA

PFGC

PTON

８月３日（水）午前８時３０分（米国東部時間）に公表される消費者物価指数（CPI）速報に先駆け、主要指数先物は神経質な値動きを示している。債券利回りは消費者物価指数発表前に低下している。今回の報告が価格圧力の緩和が続いていることを確認した場合、米連邦準備制度理事会（FRB）は利上げを余儀なくされる可能性がある。経済学者やストラテジストは、FRB総裁のジェローム・パウエル氏が今月末に予定されている＜ジャクソンホール・シンポジウム＞で、利上げ見通しについてさらに明確な見解を示すと予想している。

ウォール・ストリート　主要先物指数が反応

Cardinal Health Inc

CARRIER ALLIANCE HLDGS by Carrier Alliance Holdings, Inc.

Carrier Alliance Holdings Inc

CELESTIAL ASIA SECS NEW by Celestial Asia Secs Holdings Ltd.

Celestial Asia Securities Holdings Ltd

Caro Holdings Inc

EVOLUTION MINING LTD ORD by Evolution Mining Ltd.

Evolution Mining Ltd

Editor's Note: This article has been updated to clarify that Elliott Investment Management purchased convertible senior notes of Wolfspeed and MicroStrategy.
Elliott Investment Management made several portfolio moves in the fourth quarter, closing multiple options positions and shaking up the activist firm&#8217;s <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43811538/5-top-tech-stocks-hedge-funds-have-been-bullish-on-in-q4-hint-its-not-nvidia">technology exposure</a>.
According to a new&nbsp;<a href="https://www.sec.gov/Archives/edgar/data/1791786/000101359425000294/xslForm13F_X02/primary_doc.xml" target="_blank" rel="noreferrer noopener">13-F</a>&nbsp;filing with the U.S. Securities and Exchange Commission, Elliott added the following new positions in the fourth quarter:
<ul>
<li>Wolfspeed Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) 0.25% and 1.875% convertible senior notes</li>
</ul>
<ul>
<li>NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) put options</li>
</ul>
<ul>
<li>SPDR Select Sector Fund Industrial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>) put options</li>
</ul>
<ul>
<li>SPDR S&amp;P Oil &amp; Gas Exploration &amp; Production (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOP#NYSE">XOP</a>) put options</li>
</ul>
Here's a look at all of the positions Elliott added to during the fourth quarter:
<ul>
<li>Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) increased by 369%</li>
</ul>
<ul>
<li>MicroStrategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) increased convertible senior notes by 200%</li>
</ul>
<ul>
<li>CorMedix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) increased by 85%</li>
</ul>
<ul>
<li>HDFC Bank Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HDB#NYSE">HDB</a>) increased by 6%</li>
</ul>
Here&#8217;s a look at all of the positions Elliott closed during the fourth quarter:
<ul>
<li>Catalent Inc (CTLC) </li>
</ul>
<ul>
<li>Cardinal Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>)</li>
</ul>
<ul>
<li>Unity Software Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>)</li>
</ul>
<ul>
<li>BILL Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>)</li>
</ul>
Elliott closed out of calls in several names including Arm Holdings, American Airlines and Alaska Air Group. The firm also closed multiple put positions including Equinix, Hyatt Hotels and Host Hotels.
Here's a look at all of the positions Elliott trimmed during the fourth quarter:
<ul>
<li>ICON Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) decreased by 62%</li>
</ul>
<ul>
<li>RingCentral Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RING#NYSE">RING</a>) decreased by 55%</li>
</ul>
<ul>
<li>NRG Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) decreased by 50%</li>
</ul>
<ul>
<li>Confluent Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) decreased by 37%</li>
</ul>
<ul>
<li>Southwest Airlines Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) decreased by 2%</li>
</ul>
The above information does not include call or put options that were added to or trimmed&nbsp;during the quarter.
This information was gathered using comparison tools from&nbsp;<a href="https://13f.info/13f/000101359425000294/compare/000101359424000968" target="_blank" rel="noreferrer noopener">13f.info</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43811538/5-top-tech-stocks-hedge-funds-have-been-bullish-on-in-q4-hint-its-not-nvidia">5 Top Tech Stocks Hedge Funds Have Been Bullish On In Q4 (Hint: It&#8217;s Not Nvidia)</a></li>
</ul>
This illustration was generated using artificial intelligence via Midjourney.

Hedge Funds

BILL

CFLT

CRMD

ICLR

MSTR

RING

WOLF

Elliott Investment Management Bets Against Nvidia In Q4 (CORRECTED)

The year 2024 was an extremely fruitful one for investors, with the S&amp;P 500 Index soaring in excess of 20%. Adding to the optimism, data pertaining to manufacturing activity was impressive in January. The Institute of Supply Management&#39;s survey, released earlier this month, showed that its manufacturing PMI jumped to 50.9 in January, the highest reading since September 2022. The significant decline in inflation followed by the Fed&#39;s rate cuts has gone a long way in boosting the demand scenario. Donald Trump&#39;s return as President has also added to the optimism.
Given this encouraging backdrop, investors would do well to keep a tab on broker-friendly stocks like Dana DAN, Camping World CWH, ABM Industries ABM, Cardinal Health CAH and DXC Technology DXC.
We have designed a screen to shortlist stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks. Also, since the price/sales ratio is a strong complementary valuation metric in the presence of broker information, it has been included. The price/sales ratio takes care of the company&#39;s top line, making the strategy a well-rounded one.
<h2>Screening Criteria</h2>
# (Up- Down Rating)/ Total (4 weeks) =Top #75&nbsp;(This gives the list of the top 75 companies that have witnessed net upgrades over the last 4 weeks).
% change in Q (1) est. (4 weeks) = Top #10&nbsp;(This gives the top 10 stocks that have witnessed earnings estimate revisions over the past 4 weeks for the upcoming quarter).
Price-to-Sales = Bot%10&nbsp;(The lower the ratio, the better. Companies meeting this criterion are in the bottom 10% of our universe of over 7,700 stocks with respect to this ratio).
Price greater than 5&nbsp;(as a stock trading below $5 will not likely create significant interest for most of the investors).
Average Daily Volume greater than 100,000 shares over the last 20 trading days&nbsp;(Volume has to be significant to ensure that these are easily traded).
Market value ($ mil) = Top #3000&nbsp;(This gives us stocks that are the top 3000 in terms of market capitalization).
Com/ADR/Canadian= Com&nbsp;(This takes out the ADR and Canadian stocks).
Here are five of the 10 stocks that made it through the screen:
Dana&nbsp;is a provider of power conveyance and energy-management solutions for vehicles and machinery in North America, Europe, South America and the Asia Pacific. The company is headquartered in Maumee, OH.
DAN currently sports a Zacks Rank #1 (Strong Buy). The Zacks Consensus Estimate for DAN&#39;s 2025 earnings has been revised 15.4% upward over the past 60 days.
You can see&nbsp;<a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link&amp;ICID=zpi%20_1link" target="_blank">the complete list of today&#39;s Zacks #1 Rank stocks here</a>
Camping World Holdings, currently carrying a Zacks Rank #2 (Buy), retails recreational vehicles and related products and services in the United States. It operates through two segments, Good Sam Services and Plans and RV and Outdoor Retail.
The company aims to capitalize on the current favorable environment for dealership mergers and acquisitions. CWH outpaced the Zacks Consensus Estimate for earnings in two of the last four quarters and missed the mark in the other two. The average beat was 16.6%.
New York-based&nbsp;ABM Industries&nbsp;is a provider of integrated facility solutions in the United States and other countries. ABM currently carries a Zacks Rank #2. The company has an impressive surprise history, with its earnings surpassing the Zacks Consensus Estimate in each of the last four quarters, the average beat being 11.6%.
ABM launched ELEVATE in 2021. It is designed to drive organic growth and modernize its digital ecosystem. The acquisition of RavenVolt in 2022 strengthened the company&#39;s presence in EV infrastructure and power solutions.
Cardinal Health is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. CAH has two reporting segments &mdash; Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution and Others.
Cardinal Health has an expected earnings growth rate of 5.3% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 1.4% over the last 60 days. CAH currently carries a Zacks Rank #2.&nbsp;
DXC Technology&nbsp;is benefiting from strength in the digital business and partnerships, which are helping it expand in the cloud computing space. DXC is implementing robust cost-saving measures to enhance its financial performance.
Over the past 60 days, the Zacks Consensus Estimate for DXC Technology&#39;s current-year earnings has increased 5.4%. DXC&#39;s earnings surpassed estimates in the last four quarters, the average beat being 22.2%. The company currently carries a Zacks Rank #3 (Hold).
You can get the rest of the stocks on this list by signing up now for a 2-week free trial to the Research Wizard stock picking and backtesting software. You can also create your own strategies and test them first before making investments.
The Research Wizard is a great place to begin. It&#39;s easy to use. Everything is in plain language. And it&#39;s very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
<a href="https://woas.zacks.com/zcom/researchwizard/tools3.php?site=ZCOM_RW_IND_ARTICLES">Click here to sign up for a free trial to the Research Wizard today</a>.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks&#39; portfolios and strategies are available at:&nbsp;<a href="https://www.zacks.com/performance">https://www.zacks.com/performance</a>
&nbsp;
<h2>Only $1 to See All Zacks&#39; Buys and Sells</h2>
We&#39;re not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like&nbsp;Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.
<a href="https://www.zacks.com/registration/ultimatetrader/welcome/eoffer/6328?adid=SYND_BENZ_ZU_ZU_ANALYSTBLOG_259_IND_02182025_2417283&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283" style="font-weight:bold">See Stocks Now &gt;&gt;</a>
&nbsp;
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BST_LP194&amp;ADID=SYND_BENZ_7BEST_ANALYSTBLOG_259_2417283&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283" target="_blank">Click to get this free report</a>

&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=CAH&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_259_2417283_CAH&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283">Cardinal Health, Inc. (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/cah#NYSE">CAH</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=ABM&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_259_2417283_ABM&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283">ABM Industries Incorporated (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=DAN&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_259_2417283_DAN&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283">Dana Incorporated (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/dan#NYSE">DAN</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=CWH&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_259_2417283_CWH&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283">Camping World (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/cwh#NYSE">CWH</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=DXC&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_259_2417283_DXC&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283">DXC Technology Company. (DXC): Free Stock Analysis Report</a>
<a href="https://www.zacks.com/stock/news/2417283/5-broker-loved-stocks-to-keep-an-eye-on-after-recent-analyst-upgrades?cid=CS-BENZ-FT-analyst_blog|rw-2417283">To read this article on Zacks.com click here.</a>
<a href="https://www.zacks.com/">Zacks Investment Research</a>

Upgrades

Small Cap

Analyst Ratings

5 Broker-Loved Stocks To Keep An Eye On After Recent Analyst Upgrades

General

13F Shows Elliott Investment Management Cuts Share Stake In Southwest Airlines Co By 2.4% To 59.7M Shares, Dissolves Share Stake In Cardinal Health Inc, Cuts Share Stake In NRG Energy Inc By 50.4% To 4.8M Shares

Elliott Investment Management Dissolves Share Stake In Cardinal Health Inc

Biotech

BNTX

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

MRNA

MSOS

RFK Jr. Has Been Confirmed As The Next Health And Human Services Secretary

Cardinal Health's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) short percent of float has fallen 6.61% since its last report. The company recently reported that it has 4.42 million shares sold short, which is 2.4% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.74 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Cardinal Health Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739383213_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Cardinal Health has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Cardinal Health's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Cardinal Health's peer group average for short interest as a percentage of float is 4.58%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(CAH) - Analyzing Cardinal Health's Short Interest

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird analyst Peter Arment upgraded Mercury Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>) from Neutral to Outperform and raised the price target from $37 to $58. Mercury shares closed at $42.09 on Tuesday. <a href="https://www.benzinga.com/quote/MRCY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Brian Tanquilut upgraded the rating for Cardinal Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) from Hold to Buy and raised the price target from $140 to $150. Cardinal Health shares closed at $125.17 on Tuesday. <a href="https://www.benzinga.com/quote/CAH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Kenneth Worthington upgraded Janus Henderson Group plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHG#NYSE">JHG</a>) from Neutral to Overweight and boosted the price target from $44 to $53. Janus Henderson shares closed at $44.02 on Tuesday. <a href="https://www.benzinga.com/quote/JHG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Christopher Danely upgraded the rating for NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) from Sell to Neutral and raised the price target from $200 to $210. NXP Semiconductors shares closed at $202.40 on Tuesday. <a href="https://www.benzinga.com/quote/NXPI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Benchmark analyst Cody Acree upgraded Silicon Laboratories Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) from Hold to Buy and maintained the price target of $160. Silicon Laboratories shares closed at $136.60 on Tuesday. <a href="https://www.benzinga.com/quote/SLAB/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NXPI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="612" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05065433/image-40-1024x612.png" alt="" class="wp-image-766905" style="width:585px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05065433/image-40-1024x612.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05065433/image-40-300x179.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05065433/image-40-768x459.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/05065433/image-40.png 1082w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43460681/jim-cramer-says-no-to-bigbear-ai-recommends-buying-this-tech-stock">Jim Cramer Says No To BigBear.ai, Recommends Buying This Tech Stock</a></li>
</ul>

Janus Henderson Group plc Ordinary Shares

MRCY

NXPI

SLAB

This NXP Semiconductors Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

Jefferies analyst Brian Tanquilut upgrades Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) from Hold to Buy and raises the price target from $140 to $150.

Price Target

Jefferies Upgrades Cardinal Health to Buy, Raises Price Target to $150

Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) reported better-than-expected second-quarter financial <a href="https://www.benzinga.com/quote/CAH/earnings">results on Thursday</a>.
Cardinal Health posted adjusted earnings of $1.93 per share, beating market estimates of $1.76 per share. The company posted sales of $55.3 billion, topping expectations of $54.915 billion.
&#8220;We delivered strong second quarter financial results while taking significant strategic and operational actions to position us for future growth,&#8221; said Jason Hollar, CEO of Cardinal Health. &#8220;Led by robust demand across our Pharmaceutical and Specialty Solutions segment, we are again pleased to raise our fiscal 2025 enterprise guidance.&#8221;
Cardinal Health raised its FY25 non-GAAP earnings guidance from $7.75-$7.90 per share to $7.85-$8.00 per share.
Cardinal Health shares gained 1.3% to trade at $126.92 on Tuesday.
These analysts made changes to their price targets on Cardinal Health following earnings announcement.
<ul>
<li>Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to $136.</li>
<li>JP Morgan analyst Lisa Gill maintained Cardinal Health with a Neutral and raised the price target from $142 to $145.</li>
</ul>
Considering buying CAH stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="575" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04133226/image-2-5-1024x575.png" alt="" class="wp-image-765459" style="width:609px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04133226/image-2-5-1024x575.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04133226/image-2-5-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04133226/image-2-5-768x431.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04133226/image-2-5.png 1116w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43463896/mcdonalds-to-290-here-are-10-top-analyst-forecasts-for-tuesday">McDonald&#8217;s To $290? Here Are 10 Top Analyst Forecasts For Tuesday</a></li>
</ul>

Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings

JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) with a Neutral and raises the price target from $142 to $145.

JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $145

Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) with a Equal-Weight and raises the price target from $135 to $136.

Wells Fargo Maintains Equal-Weight on Cardinal Health, Raises Price Target to $136

Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) with a Overweight and raises the price target from $136 to $142.

Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $142

Guidance

Cardinal Health Raises FY25 Non-GAAP EPS Guidance From $7.75-$7.90 To $7.85-$8.00 vs $7.86 Est.

Earnings Beats

Cardinal Health Q2 2025 Adj. EPS $1.93 Beats $1.76 Estimate, Sales $55.3B Beat $54.915B Estimate

AAPL

ABCB

ALGM

APPF

Adtalem Global Education Inc. Common Stock

ATGE

BAFN

BBVA

BHLB

BOOT

CACC

CHKP

CIVB

CMCSA

CNOB

COUR

CSWI

CVCO

DECK

FBIZ

FCFS

FFWM

FINW

FISI

FLWS

FRME

GSIT

INTC

KLAC

KRNY

LPLA

MBLY

MBUU

NTCT

ONEW

PFSI

REAL

SCSC

SHEL

SILC

SIRI

SKYW

STBA

STEL

Earnings Scheduled For January 30, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Truist Securities raised the price target for Tempur Sealy International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPX#NYSE">TPX</a>) from $63 to $69. Truist Securities analyst Keith Hughes maintained a Buy rating. Tempur Sealy shares closed at $60.62 on Tuesday. <a href="https://www.benzinga.com/quote/TPX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan cut Nucor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) price target from $152 to $150. JP Morgan analyst Bill Peterson maintained an Overweight rating. Nucor shares closed at $126.55 on Tuesday. <a href="https://www.benzinga.com/quote/NUE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Scotiabank cut the price target for NextEra Energy Partners, LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEP#NYSE">NEP</a>) from $15 to $12. Scotiabank analyst Andrew Weisel maintained a Sector Perform rating. NextEra Energy Partners shares closed at $11.83 on Tuesday. <a href="https://www.benzinga.com/quote/NEP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Argus Research raised the price target for Royal Caribbean Cruises Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) from $280 to $305. Argus Research analyst John Staszak maintained a Buy rating. Royal Caribbean Cruises shares closed at $265.25 on Tuesday. <a href="https://www.benzinga.com/quote/JNJ/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel boosted Stryker Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>) price target from $400 to $450. Stifel analyst Rick Wise maintained a Buy rating. Stryker shares settled at $395.15 on Tuesday. <a href="https://www.benzinga.com/quote/SYK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities cut Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) price target from $21 to $19. B of A Securities analyst Michael McGovern maintained a Buy rating. Lyft shares closed at $13.96 on Tuesday. <a href="https://www.benzinga.com/quote/LYFT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan lifted RTX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) price target from $140 to $150. JP Morgan analyst Seth Seifman maintained an Overweight rating. RTX shares closed at $128.35 on Tuesday.  <a href="https://www.benzinga.com/quote/RTX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham boosted the price target for F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) from $285 to $360. Needham analyst Matt Dezort maintained a Buy rating. F5 shares settled at $269.72 on Tuesday. <a href="https://www.benzinga.com/quote/FFIV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo boosted Cardinal Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) price target from $127 to $135. Wells Fargo analyst Stephen Baxter maintained an Equal-Weight rating. Cardinal Health shares closed at $126.27 on Tuesday. <a href="https://www.benzinga.com/quote/CAH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays increased Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) price target from $119 to $124. Barclays analyst Jeffrey Bernstein maintained an Overweight rating. Starbucks shares closed at $100.41 on Tuesday. <a href="https://www.benzinga.com/quote/SBUX/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43301090/how-to-earn-500-a-month-from-meta-platforms-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Meta Platforms Stock Ahead Of Q4 Earnings</a></li>
</ul>

FFIV

LYFT

SBUX

Starbucks To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Wednesday

Note: This story has been updated with additional details on recent moves by tech titans.
Rep. Marjorie Taylor Greene (R-Ga.) <a href="https://www.benzinga.com/insights/government/25/01/43271358/georgia-rep-marjorie-taylor-greene-bought-over-1k-worth-of-asml-holding-stock-heres-what-you-">disclosed</a> a series of new trades as President Donald Trump&#8216;s equations with the leaders of Big Tech companies and other firms evolve during his second term. Greene&#8217;s portfolio shows the addition of 14 stocks and U.S. Treasuries, in a disclosure dated Jan. 27.
What Happened: The Republican politician, Greene, who has been the representative of Georgia&#8217;s 14th congressional district since 2021 has added a total of five lots of Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), with a transaction value of $1,001-$15,000 each to her portfolio in 2025, with the most recent trade on Jan. 21.
According to Benzinga&#8217;s government trades <a href="https://www.benzinga.com/gov-trades/members/marjorie-taylor-greene">tracking tool</a>, Taylor Greene also owns two lots of Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), with the recent purchase valued at $1,001-$15,000 on Jan. 21.
Whereas, Green purchased Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and Visa Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) for the first time in 2025 on Jan. 21, valued at around $1,001-$15,000, ahead of the Federal Reserve&#8217;s interest rate decision
Here&#8217;s a summary of Greene&#8217;s trades on Jan. 21:
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Stocks/Bonds Purchased</td>
<td>Amount</td>
</tr>
<tr>
<td>Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Cardinal Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Devon Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Eli Lilly And Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Kinder Morgan Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>NextEra Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Norfolk Southern Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Occidental Petroleum Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Old Dominion Freight Line Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Palo Alto Networks Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>Visa Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>)</td>
<td>$1,001-$15,000</td>
</tr>
<tr>
<td>US Treasury Bills</td>
<td>$50,001-$100,000</td>
</tr>
</tbody>
</table>
</figure>
While she owned two lots of Palo Alto Networks worth $1,001-$15,000 and one lot of U.S. Treasury bills worth $100,001-$250,000, all other purchases in the list are the most recent, dated Jan. 21.
See Also: <a href="https://www.benzinga.com/25/01/43295664/nvidia-supplier-asml-beats-q4-earnings-as-ceo-says-ai-is-key-driver-for-growth-is-it-a-buy-sell-or-hold-heres-what-technical-analysis-suggest">Nvidia Supplier ASML Beats Q4 Earnings Estimates, CEO Says &#8216;AI Is Key Driver For Growth:&#8217; Buy, Sell, Or Hold? Here&#8217;s What Technical Analysis Suggests </a>
Apart, from these stocks, she had investments worth $1,001-$15,000 in three lots of Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), and Caterpillar Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) in 2025.
She also held one lot worth $1,001-$15,000 in Home Depot Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>), iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>), Southern Copper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCCO#NYSE">SCCO</a>), Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>), and two lots worth the same in United Parcel Service Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) and Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), in 2025.
Lastly, in 2025, she owned four lots of the same amount in JPMorgan Chase &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
Why It Matters: Members of Congress, both senators and representatives must publicly <a href="https://www.benzinga.com/insights/government/25/01/43271358/georgia-rep-marjorie-taylor-greene-bought-over-1k-worth-of-asml-holding-stock-heres-what-you-">disclose</a> any personal stock trades they make. This means they have to file a report whenever they buy or sell stock.
The STOCK Act, which became law in 2012, requires these reports to be filed within 45 days of the transaction and also mandates monthly disclosures of their financial holdings. This law aims to prevent insider trading by making sure Congress members don&#8217;t use their privileged information for personal profit in the stock market.
Major tech titans, including Tesla&#8217;s Elon Musk, Amazon&#8217;s Jeff Bezos, Meta&#8217;s Mark Zuckerberg, Apple&#8217;s Tim Cook, And Google&#8217;s Sundar Pichai have been visiting President <a href="https://www.benzinga.com/news/25/01/42935628/mark-zuckerberg-meets-donald-trump-at-mar-a-lago-mending-fences-ahead-of-gop-white-house-return">Trump's Mar-a-Lago </a>residence, reportedly seeking to shape future tech policies. 
Following Trump's victory in the 2024 U.S. presidential election, major tech leaders are shifting their strategies to align with the new administration. Zuckerberg <a href="https://www.benzinga.com/tech/25/01/42779753/mark-zuckerbergs-meta-replaces-global-affairs-chief-nick-clegg-with-republican-joel-kaplan-ahead-of-trump-inauguration">appointed Republican</a> Joel Kaplan to lead policy and donated $1 million. Google, Amazon, and Apple followed suit with similar contributions. Microsoft's Satya Nadella, who reportedly gave $500,000 to Trump&#8217;s first inauguration, is also engaging with the new administration to strengthen relations.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43263070/deepseek-buzz-batters-big-tech-but-this-analyst-says-buy-the-dip-heres-a-list-of-top-five-semiconductor-etfs-with-the-lowest-expense-rations-that-investors-could-consider">DeepSeek Buzz Batters Big Tech But This Analyst Says &#8216;Buy The Dip:&#8217; Here&#8217;s Are Top 5 Semiconductor ETFs With The Lowest Expense Ratios That You Can Consider </a></li>
</ul>
Photo courtesy: Shutterstock

Market Summary

Sector ETFs

Bonds

Politics

ETFs

AMZN

GOOG

IBIT

ODFL

PANW

SCCO

TSLA

Marjorie Taylor Greene Loads Up On Meta, Amazon, Tesla, Nvidia And Other Stocks As Donald Trump's New Equations With Big Tech Leaders Sets Stage For Growth: What Is At Stake? (UPDATED)

Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) with a Equal-Weight and raises the price target from $127 to $135.

Wells Fargo Maintains Equal-Weight on Cardinal Health, Raises Price Target to $135

A January filing shows that Representative Marjorie Taylor Greene reported a purchase in Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>), valued between $1,001 and $15,000. The transaction date is listed as January 27, 2025, with the report published on January 27, 2025.
At present, Cardinal Health shares are trading down 0.03% at $130.69.
<h3>Representative's Recent Trading Activity</h3>
In the last three years, Marjorie Taylor Greene completed 163 stock transactions totaling more than $1.14 million. Costco Wholesale and Home Depot stocks were among the largest trades. Some of the most notable transactions the Rep. has executed recently include: 
<ul>
<li>Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>): $1,001 - $15,000 Purchase</li>
<li>Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>): $1,001 - $15,000 Purchase</li>
<li>Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>): $1,001 - $15,000 Purchase</li>
</ul>
Here's a summary of Marjorie Taylor Greene's recent trades:
<table>
<thead>
<tr>
<th>Company</th>
<th>Ticker</th>
<th>Stock Type</th>
<th>Amount</th>
<th>Transaction Type</th>
<th>Transaction Date</th>
</tr>
</thead>
<tbody>
<tr>
<td>Adobe</td>
<td>ADBE</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-24</td>
</tr>
<tr>
<td>Amazon.com</td>
<td>AMZN</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-24</td>
</tr>
<tr>
<td>Applied Mat</td>
<td>AMAT</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-24</td>
</tr>
<tr>
<td>Caterpillar</td>
<td>CAT</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-24</td>
</tr>
<tr>
<td>Duke Energy</td>
<td>DUK</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2024-12-24</td>
</tr>
</tbody>
</table>
To stay updated on Marjorie Taylor Greene's trades and other congressional trades, try our <a href="https://www.benzinga.com/gov-trades/members/marjorie-taylor-greene">government trades tool</a> for live updates!
<h3>Why Congressional Transactions Matter</h3>
A congressional transaction is when any representative or senator either buys or sells an individual stock.
Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.
In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.
<h3>The Importance of Congressional Transactions</h3>
Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.
When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.
A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Government

ADBE

AMAT

A Congress Member Bought Up To $15K In Cardinal Health Stock: Here's What You Need To Know

JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) with a Neutral and raises the price target from $132 to $142.

JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $142

Press Releases

Cardinal Health announces two strategic additions to its portfolio

GI Alliance to Partner with Cardinal Health Creating a Scaled Multi-Specialty Managed-Services Platform to Benefit Physicians and Patients

Court Square Capital Partners Announces Sale of Advanced Diabetes Supply Group

Cardinal Health launches Kendall SCD SmartFlow™ Compression System

Health Care

T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens

Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30

RPM Announces Appointment of Three New Board Members

Cardinal Health to open new distribution center in Fort Worth, Texas

Cardinal Health Reports Second Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook

Comments

Cardinal Health

ニュース

パートナーシップ

ベンジンガ・グローバル